Hohmann, Elizabeth L.

Remdesivir for the Treatment of Covid-19 — Final Report

Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 7,267

Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant

DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y.-B., & Hohmann, E. L. (2019) · New England Journal of Medicine

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 1,281

Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients

Kelly, C. R., Ihunnah, C., Fischer, M., Khoruts, A., Surawicz, C., Afzali, A., Aroniadis, O., Barto, A., Borody, T., Giovanelli, A., et al. (2014) · American Journal of Gastroenterology

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 636

Oral, Capsulized, Frozen Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection

Youngster, I., Russell, G. H., Pindar, C., Ziv-Baran, T., Sauk, J., & Hohmann, E. L. (2014) · JAMA

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 629

Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study

Youngster, I., Sauk, J., Pindar, C., Wilson, R. G., Kaplan, J. L., Smith, M. B., Alm, E. J., Gevers, D., Russell, G. H., & Hohmann, E. L. (2014) · Clinical Infectious Diseases

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 467

Universality of human microbial dynamics

Bashan, A., Gibson, T. E., Friedman, J., Carey, V. J., Weiss, S. T., Hohmann, E. L., & Liu, Y.-Y. (2016) · Nature

Gut microbiota and healthMicrobial Community Ecology and Physiology

Cited by 270

Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial

Sims, M. D., Khanna, S., Feuerstadt, P., Louie, T. J., Kelly, C. R., Huang, E. S., Hohmann, E. L., Wang, E. E. L., Oneto, C., Cohen, S. H., et al. (2023) · JAMA Network Open

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 83

Fecal Transplant for Recurrent Clostridium difficile Infection in Children With and Without Inflammatory Bowel Disease

Russell, G. H., Kaplan, J. L., Youngster, I., Baril‐Dore, M., Schindelar, L., Hohmann, E., & Winter, H. S. (2014) · Journal of Pediatric Gastroenterology and Nutrition

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 64

In vivo expression of Salmonella enterica serotype Typhi genes in the blood of patients with typhoid fever in Bangladesh

Sheikh, A., Charles, R. C., Sharmeen, N., Rollins, S. M., Harris, J. B., Bhuiyan, M. S., Arifuzzaman, M., Khanam, F., Bukka, A., Kalsy, A., et al. (2011) · PLoS neglected tropical diseases

Salmonella and Campylobacter epidemiologyBacterial Genetics and Biotechnology

Cited by 47